Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
CAMBRIDGE, U.K., April 16, 2002 (PRIMEZONE) -- Astex Technology, the U.K. structure-based drug discovery company, today announced the appointment of Peter Fellner as non-executive Chairman of the...
-
CAMBRIDGE, U.K., March 25, 2002 (PRIMEZONE) -- Astex Technology, the private, structure-based drug discovery company, today announced a structural biology research agreement with Aventis...
-
CAMBRIDGE, U.K., March 25, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, announced today that it has received the first milestone payment from AstraZeneca AB, as...
-
CAMBRIDGE, U.K., Feb. 20, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography technology, today announced the...
-
CAMBRIDGE, U.K., Jan. 23, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography technology, today announced the...
-
CAMBRIDGE, U.K., Dec. 17, 2001 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography (HTX(tm)) technology, today...
-
CAMBRIDGE, U.K., Dec. 17, 2001 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography (HTX(tm)) technology, today...
-
CAMBRIDGE, UK, Nov. 20, 2001 (PRIMEZONE) -- Astex Technology, the UK structure-based drug discovery company, today announced the appointment of Jon Saxe to the Board. Mr. Saxe was President of...